U.S., Jan. 28 -- An application to own the trademark for 'BARTONEX' has been filed on Aug. 11, 2025.
Owner(s):
Celsus Pharmaceuticals LLC; 106 Noroton Ave STE 101, , CONNECTICUT
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of bartonella bacteria, tick born infections, Lyme disease, and malaria
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2026-01-27&serialNumber=99330267
Disclaimer: Curated by HT Syndication....